Alnylam Pharmaceuticals ALNY
NASDAQ ALNY
$255.36 -0.60 (-0.23%)
At close: Sep 28, 2026 · 4:00 PM EDT

Alnylam Pharmaceuticals (ALNY) EV to EBITDA (2024 - 2026)

Updated

Alnylam Pharmaceuticals' EV to EBITDA came in at 35.04 for Q2 2026, down 31.3% from the prior quarter.

Analysis

Alnylam Pharmaceuticals (ALNY) EV to EBITDA (2024 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Alnylam Pharmaceuticals reported EV to EBITDA of 26.84; for FY2025, it came in at 89.25.

  • Business Quant data shows ALNY's EV to EBITDA at 50.99 (Q1 2026), 89.25 (Q4 2025) and 178.72 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn
10 Alnylam Pharmaceuticals 34.23 Bn 22.28 Bn 992.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 35.04
Mar 31, 2026 50.99
Dec 31, 2025 89.25
Sep 30, 2025 178.72
Jun 30, 2024 180.38
API Access

Alnylam Pharmaceuticals EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=ALNY&period=max&api_key=YOUR_API_KEY